The things that kill your start-up
Michio is currently the Head of the UMZH Translational Medicine Accelerator where he supports innovation and entrepreneurship in the field of life science. His talk will focus on start-up development, with special focus on issues that can kill a start-up.
From idea to bedside, a roller coaster ride
What really happens between breakthrough science and a signed biotech deal? A founder’s candid perspective.
Mohaned co-founded FimmCyte in 2022 with a mission to lead the development of disease-modifying therapies for fibro-inflammatory diseases, with a primary focus on women’s health.
Timeline
12:00 - 12:25 Michio Painter
12:25 - 12:50 Mohaned Shilaih
12:50 - 13:00 Q&A
